HIA
EW icon

HFM Investment Advisors’s Edwards Lifesciences EW Stock Holding History

HFM Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99K Buy
22
+9
+69% +$754 ﹤0.01% 457
2026
Q1 		$1.04K Buy
13
+2
+18% +$165 ﹤0.01% 398
2025
Q4 		$938 Sell
11
-1
-8% -$82 ﹤0.01% 478
2025
Q3 		$933 Hold
12
– – ﹤0.01% 407
2025
Q2 		$939 Buy
12
+6
+100% +$447 ﹤0.01% 383
2025
Q1 		$435 Buy
+6
New +$429 ﹤0.01% 335

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

HFM Investment Advisors's EW Position: Q2 2026 in Review

HFM Investment Advisors increased its Edwards Lifesciences (EW) stake by 69% in Q2 2026, buying an estimated $754 and bringing the position to 22 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

HFM Investment Advisors first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HFM Investment Advisors held 22 shares of Edwards Lifesciences worth $1.99K as of Q2 2026.
  • HFM Investment Advisors bought 9 Edwards Lifesciences shares in Q2 2026, an estimated $754.
  • Edwards Lifesciences made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #457 holding.
  • HFM Investment Advisors first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.